The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ₹233 crore compared to ₹210 crore in the same quarter last year.

Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa. The Company is ...

Veer Hanuman, an upcoming epic series, showcases the journey of Lord Hanuman with a stellar cast and spectacular visuals.

AM(IST)on Friday in a weak market. Ajanta Pharma Ltd.(up 0.58 per cent) were among the top gainers. Natco Pharma Ltd.(down ...

Quarterly Net Profit at Rs. 232.88 crore in December 2024 up 10.88% from Rs. 210.03 crore in December 2023. EBITDA stands at Rs. 351.27 crore in December 2024 up 7.21% from Rs. 327.66 crore in ...

Quarterly Net Profit at Rs. 252.45 crore in December 2024 up 14.67% from Rs. 220.15 crore in December 2023. EBITDA stands at Rs. 369.56 crore in December 2024 up 8.4% from Rs. 340.91 crore in December ...

Ajanta Pharma Ltd is quoting at Rs 2786.7, up 2.5% on the day as on 12:44 IST on the NSE. The stock is up 28.7% in last one year as compared to a 6.9% gain in NIFTY and a 15.64% gain in the Nifty ...

One of the standout aspects of the show is its intricately designed costumes, which draw inspiration from the exquisite ...

The main industry in which Ajanta Pharma Ltd operates is Pharmaceuticals - Indian - Formulations. Auditor/Auditors for Ajanta Pharma Ltd is/are B S R & Co LLP. In the main management, Mannalal B ...

Article Kolkata: Airport metro’s 135-m long ‘box-pushing’ tunnel to be India’s longest Jan 29, 2025India has embarked on its longest 'box-pushing' tunneling project beneath the Kolkata ...